Answers are grounded in this paper and cite their sources.
Clinical insights reveal that antiplatelet therapy impacts hemorrhagic transformation outcomes after stenting in stroke patients, suggesting safe management strategies.
HT remains a relevant complication after emergent intracranial stenting, particularly in patients with parenchymal hematoma. High-intensity antiplatelet therapy appears safe in select HT subtypes and was linked to reduced occlusion and mortality.
No takes yet. Share an insight, caveat, or question.
Olivé-Gadea et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: